InterQual, Milliman: Two Step Process Admission review is often a two step process: 1. Review by case manager against objective criteria 2. Secondary review by physician to determine medical necessity for admission for those cases that fail to pass admission screening.
Methocarbamol is a central muscle relaxant used to treat skeletal muscle spasms. Under the trade name Robaxin, it is marketed by Actient Pharmaceuticals in the United States and Pfizer in Canada. The mechanism of action of methocarbamol is currently unknown, but may involve the inhibition of carbonic anhydrase.
For the tablet version of the drug, the recommended starting dose of methocarbamol is 1500 mg, four times daily, for the first two or three days of treatment. The amount should then be reduced to 1500 mg twice daily, 1000 mg four times daily, or 750 mg six times daily.